1. 智能化融合:发展数据挖掘、集成、分析、可视化及人工智能工具,实现数据与文献、模型、计算等资源的有机融合,促进领域数智驱动科研新范式变革.
2. 标准化体系建设:以统一的数据标准管理体系为基础,系统整合全链条多源异构数据,聚焦高价值业务需求,精准构建结构合理、标注规范、语义清晰的数据资源.
3. 开放共享生态:开展数据提供方、使用方和服务方生态体系建设,实现多元主体间数据共享、共用、共治。.
4. 多模态数据处理:构建“全模态数据治理平台+高质量数据服务”一体化解决方案,提升非结构化数据处理能力.

Ibrutinib, also known as PCI-32765, is a potent and orally active BTK inhibitor. Ibrutinib binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting...
Li, Xixiang; Wang, Aoli; Yu, Kailin; Qi, Ziping; Chen, Cheng; Wang, Wenchao; Hu, Chen; Wu, Hong; Wu, Jiaxin; Zhao, Zheng; Liu, Juan; Zou, Fengming; Wang, Li; Wang, Beilei; Wang, Wei; Zhang, Shanchun; Liu, Jing; Liu, Qingsong. Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a Potent and Orally Available FLT3 Kinase Inhibitor for FLT3-ITD Positive Acute Myeloid Leukemia. Journal of Medicinal Chemistry. Volume 58. Issue 24. Pages 9625-9638. Journal; Online Computer File. (2015).
Tucatinib is a highly selective HER2 tyrosine kinase inhibitor that exhibits strong antiproliferative activity in HER2-positive cancer cell lines, including BT-474 and SK-BR-3, with IC₅₀ values in the...
Synthesis and in vivo evaluation of [11C]tucatinib for HER2-targeted PET imagingBy: Muller, Marius; et alBioorganic & Medicinal Chemistry Letters (2023), 80, 129088
Pacritinib (SB1518) is an orally bioavailable multikinase inhibitor with selectivity for JAK2 and FLT3. In preclinical enzymatic assays, it inhibited JAK2 with an IC50 of ~23 nM and FLT3 with an IC50 ...
Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and LymphomaBy: William, Anthony D.; et alJournal of Medicinal Chemistry (2011), 54(13), 4638-4658
Macimorelin Acetate is a ghrelin receptor agonist which exerts an anticonvulsant effect.
Chen, Yonghan; Liu, Jian; Ma, Yaping; Yuan, Jiancheng. Process for preparation of macimorelin by solid phase peptide synthesis method. CN 105330720. (Assignee Hybio Pharmaceutical Co., Ltd., Peop. Rep. China)
Avutometinib, also known as RO5126766 and CH5126766, is a protein kinase inhibitor specific for the Raf and MEK mitogen-activated protein kinases (MAPKs) with potential anti-neoplastic activity. Raf/M...
Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen ScanningBy: Aoki, Toshihiro; et alACS Medicinal Chemistry Letters (2014), 5(4), 309-314
Quizartinib (AC220) is a potent, selective FLT3 inhibitor with sub-nanomolar biochemical potency (FLT3 ITD IC₅₀ ≈ 1–2 nM) and >10-fold selectivity over most kinases. In FLT3-ITD–positive AML cell line...
Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) InhibitorBy: Chao, Qi; et alJournal of Medicinal Chemistry (2009), 52(23), 7808-7816
Doxecitine (also known as SR-13668) is an orally bioavailable PI3K/Akt inhibitor. In vitro, it suppresses proliferation of a broad range of human tumor cell lines (colon, breast, prostate) with GI50 v...
Gosselin G, Imbach JL, Bryant ML. β-L-2'-deoxy-nucleosides for the treatment of hepatitis B.US20100152126 (2010).
Florbetapir F-18 is a PET agent for Abeta plaques.
Liu, Yajing; Zhu, Lin; Ploessl, Karl; Choi, Seok Rye; Qiao, Hongwen; Sun, Xiaotao; Li, Song; Zha, Zhihao; Kung, Hank F. Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease. Nuclear Medicine and Biology. Volume 37. Issue 8. Pages 917-925. Journal. (2010).
Apalutamide, also known as ARN-509 and JNJ-56021927 , is an androgen receptor antagonist with potential antineoplastic activity. ARN-509 binds to AR in target tissues thereby preventing androgen-induc...
Pang, Xuehai; Wang, Yingwei; Chen, Yuanwei. Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles. Bioorganic & Medicinal Chemistry Letters. Volume 27. Issue 12. Pages 2803-2806. Journal; Online Computer File. (2017).
Sonidegib, also known as, erismodegib, LDE225, NVP-LDE225, is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Erismodegib selectively binds to...
Reference: Wang, Deyin; Xu, Xin; Qi, Yuxin; Wang, Baolin; Zhang, Wei; Zhao, Yinlong. Preparation of Sonidegib and intermediate thereof. CN 109293649. (Xinfa Pharmaceutical Co., Ltd., Peop. Rep. China)
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
